PROTEIN PHOSPHATASE 1В IN THE PATHOGENESIS OF LARYNGEAL AND HYPOPHARYNGEAL CANCER

To predict the development and clinical course of squamous cell head and neck carcinoma (SCHNC), we studied the level of protein phosphatase 1B (РРМ1В) using the proteomic analysis. Verification of the results of proteomic analysis by ELISA showed that the level of РРМ1В in blood serum of patients with SCHNC depended on the disease stage. The level of РРМ1В in the blood serum of patients with stage T1N0M0 cancer was higher than that observed in the control group and in patients with chronic hyperplastic laryngitis. In tumor tissue, the level of РРМ1В was associated with the size of the primary tumor and the presence of metastases. In tumor tissue, the level of РРМ1В was also higher in patients with stage T1N0M0 than in patients with chronic hyperplastic laryngitis. The data obtained indicate that the level of РРМ1В can be used for early detection and prediction of the clinical course of SCHNC. Further studies with larger cohorts of patients are required to evaluate the prognostic significance of the РРМ1В level.

1. Choinzonov E.L., Kondakova I.V., Spirina L.V., Lebedev I.N., Goldberg V.E., Chizhevskaya S.Yu., Shishkin D.A., Urazova L.N., Kakurina G.V., Bychkov V.A., Khrichkova T.Yu., Melnikov A.A. Squamous cell head and neck carcinoma: Molecular bases of pathogenesis. Moscow, 2016; 224. [in Russian].

2. Surkova P.V., Frolova I.G., Choinzonov E.L., Cheremisina O.V., Velichko S.A., Chizhevskaya S.Yu., Zel’chan R.V. Possibilities of spiral computed tomography in assessing the effectiveness of preoperative chemotherapy in patients with laryngeal and laryngopharyngeal cancer. Siberian Journal of Oncology. 2011; 2: 39–44. [in Russain]

3. Leenman E.E., Mukhina M.S. The cellular microenvironment of malignant tumors and its significance in their prognosis. Problems in Oncology. 2013; 59 (4): 444–52. [in Russian

4. El’nikova A.A. Tumor microenvironment a dark horse in anticancer chemotherapy. Health and education at XXI сentury. 2015; 17 (1): 84–86. [in Russian]

5. Sun W., Yu Y., Dotti G., Shen T., Tan X., Savoldo B., Pass A.K., Chu M., Zhang D., Lu X., Fu S., Lin X., Yang J. PPM1A and PPM1B act as IKKbeta phosphatases to terminate TNFalpha induced IKKbeta NF kappaB activation. Cell Signal. 2009 Jan; 21(1): 95–102. doi: 10.1016/j.cellsig.2008.09.012.

6. Takeuchi T., Kobayashi T., Tamura S., Yokosawa H. Negative regulation of protein phosphatase 2Cbeta by ISG15 conjugation. FEBS Lett. 2006 Aug 7; 580 (18): 4521–6.

7. Wang H., Chen Y., Han J., Meng Q., Xi Q., Wu G., Zhang B. DCAF4L2 promotes colorectal cancer invasion and metastasis via mediating degradation of NFκb negative regulator PPM1B. Am J Transl Res. 2016 Feb 15; 8 (2): 405–18.

8. Yang J., Yuan D., Li J., Zheng S., Wang B. MiR-186 downregulates protein phosphatase PPM1B in bladder cancer and mediates G1-S phase transition. Tumour Biol. 2016 Apr; 37 (4): 4331–41. doi: 10.1007/s13277-015-4117-4.

9. Zuo S., Xue Y., Tang S., Yao J., Du R., Yang P., Chen X. 14-3-3 epsilon dynamically interacts with key components of mitogen-activated protein kinase signal module for selective modulation of the TNF-alpha-induced time course-dependent NF-kappaB activity. J Proteome Res. 2010 Jul 2; 9 (7): 3465–78. doi: 10.1021/pr9011377.

10. Chen W., Wu J., Li L., Zhang Z., Ren J., Liang Y., Chen F., Yang C., Zhou Z., Su S.S., Zheng X., Zhang Z., Zhong C.Q., Wan H., Xiao M., Lin X., Feng X.H., Han J. Ppm1b negatively regulates necroptosis through dephosphorylating Rip3. Nat Cell Biol. 2015 Apr; 17 (4): 434–44. doi: 10.1038/ncb3120.